60 Degrees Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $125 | $146 | $42 | $51 |
Gross Profit | 36 | 80 | -103 | -20 |
EBITDA | -4,177 | -1,309 | -1,870 | 4,538 |
EBIT | -4,188 | -1,331 | -1,894 | 4,512 |
Net Income | -4,169 | 430 | -1,958 | 4,183 |
Net Change In Cash | 125 | 146 | 42 | 51 |
Free Cash Flow | -1,318 | -1,150 | -130 | -3,780 |
Cash | 1,576 | 2,894 | 2,142 | 2,218 |
Basic Shares | 1,014 | 10,124 | 5,810 | 5,799 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $253 | $223 | $1,160 | $2,181 |
Gross Profit | -220 | -209 | 309 | 1,478 |
EBITDA | -5,054 | -1,714 | -1,014 | -341 |
EBIT | -5,154 | -1,793 | -1,086 | -369 |
Net Income | -3,703 | -6,181 | -4,251 | -3,033 |
Net Change In Cash | 253 | 223 | 1,160 | 2,181 |
Free Cash Flow | -4,658 | -1,070 | -684 | -238 |
Cash | 2,142 | 264 | 115 | 191 |
Basic Shares | 5,810 | 5,781 | 5,781 | 5,781 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$4.23 |
2024-03-31 | $0.03 |
2023-12-31 | -$0.35 |
2023-09-30 | $0.77 |
